Our Group Companies
Explore our group companies worldwide
Our Japanese company manufactures and commercialises Ursodeoxycholic acid (UDCA) for local and export markets.
Our Indian company manufactures and commercialises Ursodeoxycholic acid (UDCA) for the local market.
ABC develops and manufactures products for the pharmaceutical, nutraceutical and cosmetics markets, and provides CDMO services.
Our New Zealand company produces pharma grade cholic acid and exports a range of bile acid derivatives.
Our UK company specialises in carbohydrate chemistry providing products for R&D and contract manufacturing services.
An unmatched experience and expertise
With over 70 years of experience and 1500 world-wide employees, ICE Pharma provides both products and services to the pharmaceutical industry.
ICE Pharma is an expert in the development and manufacture of bile acid derivatives. We are a leading producer of Ursodeoxycholic Acid (UDCA) with an integrated global manufacturing network in Europe, Latin America, Asia and Oceania that serves customers in over 50 countries.
Our five R&D centres have enabled us to develop a unique and comprehensive range products including Generic APIs, Excipients, Finished Dosage Forms and New Chemical Entities.
Our Products & Services
We offer a comprehensive & unique range of products & services
We offer an extensive range of products for the pharmaceutical market including APIs, Finished Dosage Forms and Excipients.
We provide pharmaceutical contract development and manufacturing services for solid and liquid finished dosage forms and complex carbohydrates
Our range of branded nutraceutical supplements is focused on strengthening the immune system and gut health. We are also a provider of natural taurine.
We supply the academic and research communities with complex carbohydrates and novel bile acid derivatives.
Our branded natural cosmetics range is focused on skin care.
Our global footprint
Facilities & companies across the globe
ICE Pharma has an interconnected network of 7 manufacturing facilities in North and South America, Europe, Asia and Oceania through which we provide our customers with an unparalleled security of supply and a local service.
News & Articles
Stay up to date with ICE Pharma’s latest news, events & publications
Fourth research publication in collaboration with ICE Pharma and Ferrier Research Institute
We are proud to announce the publication of another scientific paper coming from the collaboration of ICE Pharma with the Ferrier Research Institute. This paper relates to Parkinson’s Disease...
ICE Pharma obtained the certifications ISO 45001 and ISO 50001 in its sites in Italy and New Zealand.
From planning, construction and operation of production facilities, we continue to implement global process safety standards and improve measures for incident prevention in all our plants across the world....
A recent study suggest that UDCA may help prevent Covid infection
ICE Pharma has been featured in an article in the Italian press, Il corriere della sera, concerning the huge increase in requirement for the drug Ursodeoxycholic acid in China. ...